Follow us_

Publication Search Results

Exact matches for:

• Author = Thompson JF

1. Mao Y, Gide TN, Adegoke NA, Quek C, Maher N, Potter A, Patrick E, Saw RM, Thompson JF, Spillane AJ, Shannon KF, Carlino MS, Lo SN, Menzies AM, da Silva IP, Long GV, Scolyer RA, Wilmott JS
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, Camelia Quek, Nigel Maher, Alison Potter, Ellis Patrick, Robyn M Saw, John F Thompson, Andrew J Spillane, Kerwin F Shannon, Matteo S Carlino, Serigne N Lo, Alexander M Menzies, Inês Pires da Silva, Georgina V Long, Richard A Scolyer and James S Wilmott: Cross‑platform comparison of immune signatures in immunotherapy‑treated patients with advanced melanoma using a rank‑based scoring approach, Journal of Translational Medicine, 21 (2023), 257 (16 pages).

2. Wang KYX, Pupo GM, Tembe V, Patrick E, Strbenac D, Schramm SJ, Thompson JF, Scolyer RA, Muller S, Tarr G, Mann GJ, Yang YH
Kevin Y X Wang, Gulietta M Pupo, Varsha Tembe, Ellis Patrick, Dario Strbenac, Sarah-Jane Schramm, John F Thompson, Richard A Scolyer, Samuel Muller, Garth Tarr, Graham J Mann and Jean Y H Yang: Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine, npj Digital Medicine, 5 (open Access) (2022), no. 1, Article 85.

3. Sykes EK, McDonald CE, Ghazanfar S, Mactier S, Thompson JF, Scolyer RA, Yang YH, Mann GJ, Christopherson RI
Erin K Sykes, Cassandra E McDonald, Shila Ghazanfar, Swetlana Mactier, John F Thompson, Richard A Scolyer, Jean Y Yang, Graham J Mann, Richard I Christopherson: A 14-Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma, PROTEOMICS–Clinical Applications, 12 (2018), no. 3, 1700094.

4. Madore J, Strbenac D, Vilain R, Menzies AM, Yang YH, Thompson JF, Long GV, Mann GJ, Scolyer RA, Wilmott JS
Jason Madore, Dario Strbenac, Ricardo Vilain, Alexander M Menzies, Jean Y H Yang, John F Thompson, Georgina V Long, Graham J Mann, Richard A Scolyer, and James SWilmott: PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma, Clinical Cancer Research, 22 (2016), no. 15, 3915–3923.

5. Jayawardana K, Schramm SJ, Tembe V, Muller S, Thompson JF, Scolyer RA, Mann GJ, Yang YH
K Jayawardana, S-J Schramm, V Tembe, S Mueller, JF Thompson, RA Scolyer, GJ Mann, J Yang: Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma, Journal of Investigative Dermatology, 136 (2016), 245–254.

6. Jayawardana K, Schramm SJ, Haydu L, Thompson JF, Scolyer RA, Mann GJ, Muller S, Yang YH
Kaushala Jayawardana, Sarah-Jane Schramm, Lauren Haydu, John F Thompson, Richard A Scolyer, Graham J Mann, Samuel Müller and Jean Yee Hwa Yang: Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information, International Journal of Cancer, 136 (2015), no. 4, 863–874.

7. Mactier S, Kaufman KL, Wang P, Crossett B, Pupo GM, Kohnke PL, Thompson JF, Scolyer RA, Yang YH, Mann GJ, Christopherson RI
Swetlana Mactier, Kimberley L Kaufman, Penghao Wang, Ben Crossett, Gulietta M Pupo, Philippa L Kohnke, John F Thompson, Richard A Scolyer, Jean Y Yang, Graham J Mann and Richard I Christopherson: Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients, Pigment Cell and Melanoma Research, 27 (2014), no. 6, 1106–1116.

8. Kaufman KL, Mactier S, Armstrong NJ, Mallawaaratchy D, Byrne S, Haydu L, Jakrot V, Thompson JF, Mann GJ, Scolyer RA, Christopherson. RI
K.L. Kaufman, S. Mactier, N.J. Armstrong, D. Mallawaaratchy, S. Byrne, L. Haydu, V. Jakrot, J.F. Thompson, G.J. Mann, R.A. Scolyer, R.I. Christopherson.: Surface antigen profiles of leukocytes and melanoma cells in lymph nodes correlate with survival in AJCC stage III metastatic melanoma patients., Clinical and Experimental Metastasis, 31 (2014), no. 4, 407–421.

9. Mann GJ, Pupo GM, Campain AE, Carter CD, Schramm SJ, Pianova S, Gerega SK, De Silva C, Lai K, Wilmott JS, Synnott M, Hersey P, Kefford RF, Thompson JF, Yang YH, Scolyer RA
Graham J Mann, Gulietta M Pupo, Anna E Campain, Candace D Carter, Sarah-Jane Schramm, Svetlana Pianova, Sebastien K Gerega, Chitra De Silva, Kenneth Lai, James S Wilmott, Maria Synnott, Peter Hersey, Richard F Kefford, John F Thompson, Yee Hwa Yang and Richard A Scolyer: BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma, Journal of Investigative Dermatology, 133 (2013), 509–517.

10. Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA
Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA: Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors., International Journal of Surgical Pathology, 17 (2009), no. 5, 361–367.